TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Inhalation Sciences Sweden AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
17,504
|
12,194
|
9,422 |
| Financial expenses |
995
|
103
|
38 |
| Earnings before taxes |
-4,744
|
-12,125
|
-16,609 |
| EBITDA |
-2,640
|
-10,847
|
-15,391 |
| Total assets |
18,168
|
12,985
|
26,112 |
| Current assets |
15,795
|
9,496
|
21,483 |
| Current liabilities |
4,772
|
4,574
|
5,067 |
| Equity capital |
12,954
|
7,553
|
19,678 |
| - share capital |
6,067
|
4,550
|
4,550 |
| Employees (average) |
8
|
9
|
9 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
71.3%
|
58.2%
|
75.4% |
| Turnover per employee |
2,188
|
1,355
|
1,047 |
| Profit as a percentage of turnover |
-27.1%
|
-99.4%
|
-176.3% |
| Return on assets (ROA) |
-20.6%
|
-92.6%
|
-63.5% |
| Current ratio |
331.0%
|
207.6%
|
424.0% |
| Return on equity (ROE) |
-36.6%
|
-160.5%
|
-84.4% |
| Change turnover |
5,310
|
2,772
|
-715 |
| Change turnover % |
44%
|
29%
|
-7% |
| Chg. No. of employees |
-1
|
0
|
1 |
| Chg. No. of employees % |
-11%
|
0%
|
13% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.